Table 3.
Follow-up visit modality | Baseline (before teledermatology; June to September 2019) | Early teledermatology (June to September 2020) | Sustained teledermatology (February to May 2021) | ||||||||
|
Total visits, N | In-clinic, n (%) | Total visits, N | In-clinic, n (%) | Video, n (%) | P valuea | Total visits, N | In-clinic, n (%) | Video, n (%) | P value | |
Patient age (years) | .32 |
|
.47 | ||||||||
|
<70 | 56 | 56 (100) | 72 | 30 (42) | 42 (58) |
|
71 | 36 (51) | 35 (49) |
|
|
≥70 | 18 | 18 (100) | 29 | 9 (31) | 20 (69) |
|
29 | 17 (59) | 12 (41) |
|
Distance from clinic (miles)b | .15 |
|
.01 | ||||||||
|
<21 | 36 | 36 (100) | 47 | 19 (40) | 28 (60) |
|
59 | 38 (64) | 21 (36) |
|
|
≥21 | 38 | 38 (100) | 54 | 20 (37) | 34 (63) |
|
41 | 15 (37) | 26 (63) |
|
aDifferences in proportion between in-clinic and video visits were determined using chi-square tests.
bThe median distance between the patient’s zip code and the primary dermatology clinic in Palo Alto, CA, United States was 21 miles.